James D. Miller — Endo Lab

article 2000

Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial

American journal of obstetrics and gynecology ·doi:10.1067/mob.2000.106846

ObjectiveThe purpose of this study was a quantification of changes in endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy.Study designOne hundred twenty women with…

article 1998

Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonist

Fertility and sterility ·doi:10.1016/s0015-0282(98)00166-6

ObjectiveTo determine the duration of time to the recurrence of pain attributable to endometriosis after the discontinuation of treatment with danazol or a GnRH agonist (GnRH-a) in patients who have had a satisfactory response to the treatm…

article 1997

Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata

Advanced drug delivery reviews ·doi:10.1016/s0169-409x(97)00055-0

Uterine leiomyomata and endometriosis are two common hormone-dependent pathologies effecting women of reproductive age. Prior to the introduction of gonadotropin releasing hormone agonists (GnRHa), there was no effective medical therapy for…

article 1992

Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis

American journal of obstetrics and gynecology ·doi:10.1016/s0002-9378(11)91718-9

ObjectiveWe aimed to assess the efficacy of depot leuprolide versus danazol in the treatment of endometriosis.Study designA double-blind randomized trial of 270 patients from 22 centers compared the pretreatment and posttreatment laparoscop…

article 1990

Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study

Fertility and sterility ·doi:10.1016/s0015-0282(16)53755-8

The safety and efficacy of leuprolide acetate (LA) for depot suspension (Lupron depot; TAP Pharmaceuticals, North Chicago, IL), 3.75 mg versus placebo, in the treatment of pain associated with endometriosis was assessed in a randomized, dou…